Alemtuzumab Intravenous and Reclipsen
Determining the interaction of Alemtuzumab Intravenous and Reclipsen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: desogestrel / ethinyl estradiol
Brand name: Azurette, Cyclessa, Desogen, Isibloom, Kariva, Mircette, Reclipsen, Apri, Bekyree, Caziant, Ortho-Cept, Solia, Cesia, Cyred
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Recombinate
- Alemtuzumab Intravenous-Recombinate recombinant
- Alemtuzumab Intravenous-Recombivax
- Alemtuzumab Intravenous-Recombivax HB
- Alemtuzumab Intravenous-Recombivax HB Adult
- Alemtuzumab Intravenous-Recombivax HB Dialysis Formulation
- Reclipsen-Alenaze-D
- Reclipsen-Alendronate
- Reclipsen-Alendronate and cholecalciferol
- Reclipsen-Alendronate Effervescent Tablets
- Reclipsen-Alendronate Oral Solution
- Reclipsen-Alendronate Sodium